Breast milk is the best nutrition for newborn infants. In cases where breast milk is not or insufficiently available, FrieslandCampina DOMO wants to offer the highest quality infant formula fulfilling the nutritional needs of the infant. With Aequival® 2′-FL, FrieslandCampina DOMO offers the first human milk oligosaccharide (not derived from human milk) for application in next generation infant formula.
2'-FL in infant nutrition
Oligosaccharides are a vitally important component of human milk, that are hardly present in cow’s milk1. Therefore, infant formula based on cow’s milk is currently lacking human milk oligosaccharides. FrieslandCampina DOMO is dedicated to developing human milk oligosaccharides for application in infant formula.
Production of 2'-FL
FrieslandCampina DOMO has constructed a new production plant, as part of the new, fully-owned production process for HMOs. This process will be used to make Aequival® 2’-FL commercially available soon. Check out the time-lapse of the building of the new plant here.
Three great reasons to say hi at Hi Europe
FrieslandCampina DOMO will be participating at Health Ingredients Europe 2018 in Frankfurt (Booth 8C51), 27 - 29 November. Three great reasons to say hi: Aequival 2'-FL: The first Human Milk Oligosaccharide (HMO) for next generation infant formulas. Hyvital whey EtD 100 Organic: Extend your organic portfolio with our new organic hydrolysate. Deminal 90 Liquid: Improve sustainability and proteins quality whilst lowering conversion costs. Read more
FrieslandCampina’s new Human Milk Oligosaccharide ingredient, 2’-FL, obtains EU approval and GRAS status
PRESS RELEASE FrieslandCampina DOMO’s new Human Milk Oligosaccharide (HMO) ingredient, 2’-fucosyllactose (2’-FL), has been officially certified to be used in infant formula in both European and U.S. markets. The ingredient has received EU novel food approval and achieved GRAS (Generally Recognised as Safe) status from the Food and Drug Administration (FDA) in the U.S. These authorisations are an important step forward in the plan of FrieslandCampina to launch its first human milk oligosaccharide by the end of the year. Read more
FrieslandCampina and Glycosyn partner for new infant nutrition ingredients
FrieslandCampina Domo and US-based Glycosyn are combining their expertise into a global partnership to develop new infant nutrition ingredients. The parties signed a technology and partnership agreement. Glycosyn has developed a patented technology for the production of oligosaccharides from lactose. FrieslandCampina Domo will produce and introduce these new ingredients onto the global market. Read more